NEXI-S.P.A.
9.5.2024 08:01:36 CEST | Business Wire | Press release
The Board of Directors of Nexi S.p.A. approved on May 8th the Group’s consolidated financial results as of March 31st 2024.
Key consolidated financial managerial results1
In 1Q24 the Group delivered revenues at € 781.6 million, +6.0% versus 1Q23, and EBITDA at € 361.7 million, +8.6% versus 1Q23. The EBITDA margin was at 46%, up by 112 basis points compared to 1Q23, also thanks to the accelerating efficiencies and cost synergies delivery on the back of Group integration.
Nexi Group’s operating businesses delivered the following results in 1Q24:
-
Merchant Solutions, representing approximately 56% of Group's total revenues, reported revenues of € 437.7 million, +6.8% Y/Y, with eCommerce growing double-digit driven by accelerated customer base growth and volume growth. In 1Q24, 4,514 million transactions were processed, +9.5% Y/Y, with value of processed transactions at € 192.5 billion, +5.0% Y/Y. In 1Q24 there has been a continued international schemes sales volume growth in all geographies, with DACH region growing double-digit Y/Y and Italy high single-digit. During the quarter, SMEs acquiring volumes continued to grow driven by customer base expansion, particularly in Italy and DACH region.
Nexi firmly believes that convergence of digital payments and software for SME is a topic that will contribute to shape the industry in the next years. Therefore, Nexi continues to reinforce its position as the "partner of choice" in Europe for best-in-class local ISVs, with >500 ISVs partners in 8 markets and POS solutions already being sold by Nexi channels in the Nordics and Germany, to be extended over time to additional markets and verticals.
- Issuing Solutions, representing approximately 33% of Group's total revenues, reported revenues of € 257.6 million in 1Q24, +5.2% Y/Y. The growth was mainly supported by the performance in Italy, benefitting from the acceleration of international debit. In 1Q24, 4,737 million transactions were processed, +8.2% Y/Y, with value of processed transactions at € 207.9 billion, +4.6% Y/Y.
- Digital Banking Solutions, representing approximately 11% of Group's total revenues, reported revenues of € 86.3 million, +4.3% Y/Y, sustained by volume growth and positive impact from new initiatives. Specifically, during the first quarter, Nexi launched a new pan-European antifraud solution for EBA Clearing’s SEPA credit transfers and Instant payments.
In 1Q24, Total Costs were at € 419.9 million, with a growth of 3.8% Y/Y mainly thanks to the operating leverage and to synergies and efficiencies, as well as some phasing effects, despite volume and business growth and inflationary pressure.
As of March 31st 2024, the Net Financial Debt was down to € 5,035 million, while the Net Financial Debt / EBITDA ratio decreased at 2.8x. The weighted average debt maturity is ~2.8 years with an average pre-tax cash cost of debt, stable versus FY23, of ~2.86%. With reference to the ~€ 1.3 billion of 2024-2025 debt maturities, Nexi confirms its plan to fully pay down them with the existing cash; in particular, ~€ 220 million have been already reimbursed in April 2024.
2024 Guidance confirmed
For 2024, considering the persistent complex macro-outlook, Nexi confirms the following targets:
- Net revenues: Mid-single digit Y/Y growth;
- EBITDA: Mid-to-high single digit Y/Y growth, with margin expansion of 100 bps+;
- Excess cash generation: More than € 700 million;
- Net leverage: decreasing to below 2.9x including announced M&A and share buy-back effects, (~2.6x on organic basis).
Significant subsequent events
-
Nexi announces the start of a share buy-back program up to 500 €M to be completed by October 31st, 2025 and already approved by the Shareholders' meeting on April 30th, 2024.
The substantial existing cash balances and the strong current and expected cash generation growth allow to start returning capital to Shareholders in 2024, while still continuing to support the planned debt reduction and the limited M&A opportunities in the future. Nexi’s management and the Board believe that the current share price does not reflect the full value of its business and outlook and that a share buy-back offers the most effective value creating opportunity for the shareholders to deploy the excess cash. In the longer term, Nexi plans to continue to allocate a material portion of excess capital to shareholders either through further share buy-back programs or dividends depending on overall market conditions.
- On April 8th, 2024, the bonds issued by Nassa TopCo AS for a nominal amount of about € 219.6 million, plus the accrued interest, were redeemed at maturity using the already available cash.
- Following the resignation of Mr. Bo Nilsson from the Board of Directors occurred on April 30th, 2024, the Board of Directors of the Company during yesterday’s meeting, appointed by co-optation Mr. Luca Velussi as a non-executive and non independent Director, after the favorable opinion of the Board of Statutory Auditors. His curriculum vitae is available in the governance section of the company website www.nexigroup.com. Mr. Luca Velussi will remain in post until the next Shareholders' Meeting and, as of today, does not own any Nexi share.
Pursuant to paragraph 2 of article 154 bis of the Consolidated Finance Act, the undersigned, Enrico Marchini, in his capacity as the manager in charge of preparing Nexi’s financial reports, declares that the accounting information contained in this press release corresponds to the accounting documents, books and records of Nexi S.p.A..
Disclaimer: This is the English translation of the original Italian press release “Approvati i risultati finanziari di Gruppo al 31 marzo 2024”. In any case of discrepancy between the English and the Italian versions, the original Italian document is to be given priority of interpretation for legal purposes.
Nexi
Nexi is Europe's PayTech company operating in high-growth, attractive European markets and technologically advanced countries. Listed on Euronext Milan, Nexi has the scale, geographic reach and abilities to drive the transition to a cashless Europe. With its portfolio of innovative products, e-commerce expertise and industry-specific solutions, Nexi provides flexible support for the digital economy and the entire payment ecosystem globally, across a broad range of different payment channels and methods. Nexi’s technological platform and the best-in-class professional skills in the sector enable the company to operate at its best in three market segments: Merchant Solutions, Issuing Solutions and Digital Banking Solutions. Nexi constantly invests in technology and innovation, focusing on two fundamental principles: meeting, together with its partner banks, customer needs and creating new business opportunities for them. Nexi is committed to supporting people and businesses of all sizes, transforming the way people pay and businesses accept payments. It offers companies the most innovative and reliable solutions to better serve their customers and expand. By simplifying payments and enabling people and businesses to build closer relationships and grow together, Nexi promotes progress to benefit everyone. www.nexi.it/en www.nexigroup.com
1 2023 and 2024 pro-forma normalised managerial data at constant scope and FX (average 2024 budget FX).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240508329060/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease1.5.2026 23:28:00 CEST | Press release
Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi®(ruxolitinib)Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily JakafiJakafi XR will be available for pharmacy orders by May 8 Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meetin
Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 18:08:00 CEST | Press release
Drivers and team members of Formula 1® were reunited with their loved ones during a night that also celebrated the new partnership between Barilla and the Visa Cash App Racing Bulls Formula 1® Team. A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines wer
TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 12:07:00 CEST | Press release
Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the
Andersen Consulting styrker sine kompetencer inden for digital transformation med Weexa1.5.2026 10:07:00 CEST | Pressemeddelelse
Andersen Consulting indgår en samarbejdsaftale med Weexa, en global leverandør af løsninger inden for digital transformation, B2B-integration og digitalisering af forsyningskæden. Med hovedsæde i Frankrig leverer Weexa end-to-end-tjenester, der hjælper organisationer med at optimere, sikre og skalere deres digitale økosystemer. Virksomheden specialiserer sig i styring af B2B-datastrømme og digitalisering, hvilket muliggør problemfri kommunikation mellem applikationer både internt og på tværs af organisationer gennem teknologier som EDI, API'er og e-fakturering. Weexa tilbyder også SAP-integration og supply chain-løsninger til styring af lager og transport, sideløbende med strategisk rådgivning, projektlevering og vedligeholdelse af tredjepartsapplikationer. Weexa betjener organisationer inden for fødevaresektoren, detailhandel, engros, logistik, transport, bilindustrien, sundheds- og mediesektoren og hjælper globale virksomheder med at optimere deres ydeevne samt at overholde de nyeste
Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 01:17:00 CEST | Press release
Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
